Citizens Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $430K | Buy |
2,346
+549
| +31% | +$101K | 0.01% | 580 |
|
|
2025
Q4 | $316K | Sell |
1,797
-200
| -10% | -$32.7K | ﹤0.01% | 646 |
|
|
2025
Q3 | $280K | Buy |
1,997
+206
| +12% | +$27.8K | ﹤0.01% | 663 |
|
|
2025
Q2 | $225K | Buy |
+1,791
| New | +$223K | ﹤0.01% | 640 |
|
|
2025
Q1 | – | Sell |
-1,545
| Closed | -$236K | – | 617 |
|
|
2024
Q4 | $236K | Buy |
+1,545
| New | +$261K | ﹤0.01% | 517 |
|
|
2024
Q3 | – | Sell |
-1,033
| Closed | -$239K | – | 565 |
|
|
2024
Q2 | $239K | Buy |
+1,033
| New | +$224K | 0.01% | 478 |
|
|
2022
Q4 | – | Sell |
-1,015
| Closed | -$271K | – | 419 |
|
|
2022
Q3 | $271K | Hold |
1,015
| – | – | 0.01% | 337 |
|
|
2022
Q2 | $207K | Sell |
1,015
-946
| -48% | -$193K | 0.01% | 407 |
|
|
2022
Q1 | $413K | Sell |
1,961
-1,538
| -44% | -$334K | 0.01% | 308 |
|
|
2021
Q4 | $819K | Sell |
3,499
-27,652
| -89% | -$7.11M | 0.03% | 233 |
|
|
2021
Q3 | $8.82M | Buy |
31,151
+1,834
| +6% | +$601K | 0.33% | 77 |
|
|
2021
Q2 | $10.2M | Sell |
29,317
-390
| -1% | -$118K | 0.44% | 65 |
|
|
2021
Q1 | $8.31M | Sell |
29,707
-97
| -0.3% | -$26.2K | 0.44% | 72 |
|
|
2020
Q4 | $7.3M | Sell |
29,804
-695
| -2% | -$179K | 0.42% | 72 |
|
|
2020
Q3 | $8.64M | Buy |
30,499
+904
| +3% | +$252K | 0.55% | 56 |
|
|
2020
Q2 | $7.92M | Sell |
29,595
-510
| -2% | -$153K | 0.56% | 58 |
|
|
2020
Q1 | $9.53M | Sell |
30,105
-1,608
| -5% | -$488K | 0.78% | 33 |
|
|
2019
Q4 | $9.41M | Buy |
31,713
+9,154
| +41% | +$2.54M | 0.63% | 51 |
|
|
2019
Q3 | $5.25M | Sell |
22,559
-435
| -2% | -$101K | 0.38% | 81 |
|
|
2019
Q2 | $5.38M | Sell |
22,994
-818
| -3% | -$189K | 0.39% | 81 |
|
|
2019
Q1 | $5.63M | Buy |
23,812
+648
| +3% | +$204K | 0.41% | 82 |
|
|
2018
Q4 | $6.97M | Buy |
23,164
+43
| +0.2% | +$13.7K | 0.63% | 62 |
|
|
2018
Q3 | $8.17M | Sell |
23,121
-166
| -0.7% | -$57.2K | 0.64% | 61 |
|
|
2018
Q2 | $6.76M | Buy |
23,287
+22,928
| +6,387% | +$6.45M | 0.57% | 65 |
|
|
2018
Q1 | $98K | Buy |
359
+128
| +55% | +$39.7K | 0.01% | 265 |
|
|
2017
Q4 | $74K | Hold |
231
| – | – | 0.01% | 298 |
|
|
2017
Q3 | $72K | Buy |
+231
| New | +$68.4K | 0.01% | 306 |
|
|
2017
Q1 | – | Sell |
-23
| Closed | -$7K | – | 628 |
|
|
2016
Q4 | $7K | Hold |
23
| – | – | ﹤0.01% | 480 |
|
|
2016
Q3 | $7K | Hold |
23
| – | – | ﹤0.01% | 484 |
|
|
2016
Q2 | $6K | Sell |
23
-75
| -77% | -$19.8K | ﹤0.01% | 521 |
|
|
2016
Q1 | $26K | Hold |
98
| – | – | ﹤0.01% | 415 |
|
|
2015
Q4 | $30K | Buy |
+98
| New | +$28.2K | ﹤0.01% | 412 |
|
Other funds holding BIIB
VCM
VPM
Citizens Financial Group's BIIB Position: Q1 2026 in Review
Citizens Financial Group increased its Biogen (BIIB) stake by 31% in Q1 2026, buying an estimated $101K and bringing the position to 2,346 shares worth $430K. The position accounts for 0.01% of the portfolio, ranked #580.
Citizens Financial Group first reported a position in BIIB in Q4 2015 and has held it in 32 quarters since. The position peaked at $10.2M in Q2 2021. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Citizens Financial Group held 2,346 shares of Biogen worth $430K as of Q1 2026.
- Citizens Financial Group bought 549 Biogen shares in Q1 2026, an estimated $101K.
- Biogen made up 0.01% of Citizens Financial Group's portfolio in Q1 2026, its #580 holding.
- Citizens Financial Group first reported a position in Biogen in Q4 2015 and has held it in 32 quarters since.
- Citizens Financial Group's Biogen position peaked at $10.2M in Q2 2021.
- 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.